Key Takeaway
TGA issues alert after person was hospitalised after believing they were taking experimental weight loss drug retatrutideFollow our Australia news live blog for latest updatesGet our breaking news email, free app or daily news podcastA patient who tore their oesophagus after taking a counterfeit version of an experimental weight loss drug has prompted Australia’s medicines regulator to warn of serious…
Published September 14, 2026 · Category: News
Overview
TGA issues alert after person was hospitalised after believing they were taking experimental weight loss drug retatrutide
A patient who tore their oesophagus after taking a counterfeit version of an experimental weight loss drug has prompted Australia’s medicines regulator to warn of serious risks of such products.
Details
The concern relates to retatrutide, a type of drug known as a peptide. Retatrutide has not been approved by the Therapeutic Goods Administration (TGA) or regulators overseas, and it cannot be legally prescribed or sold in Australia.
Continue reading...
Source
Originally published at www.theguardian.com.
Related Articles
Frequently Asked Questions
What is "Peptide user tore oesophagus after using counterfeit product, Australian regulator warns" about?+
TGA issues alert after person was hospitalised after believing they were taking experimental weight loss drug retatrutideFollow our Australia news live blog for latest updatesGet our breaking news email, free app or daily news podcastA patient who tore their oesophagus after taking a counterfeit version of an experimental weight loss drug has prompted Australia’s medicines regulator to warn of serious risks of such products.The concern relates to retatrutide, a type of drug known as a peptide. R
Who reported this story?+
This story was reported by The Guardian World.